BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35683190)

  • 1. Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma.
    Graur F; Puia A; Mois EI; Moldovan S; Pusta A; Cristea C; Cavalu S; Puia C; Al Hajjar N
    Materials (Basel); 2022 May; 15(11):. PubMed ID: 35683190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma.
    Liu T; Liu L; Li L; Cai J
    Mater Today Bio; 2023 Oct; 22():100766. PubMed ID: 37636988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology for Hepatocellular Carcinoma: From Surveillance, Diagnosis to Management.
    Wu H; Wang MD; Liang L; Xing H; Zhang CW; Shen F; Huang DS; Yang T
    Small; 2021 Feb; 17(6):e2005236. PubMed ID: 33448111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of Nanotechnology in the Diagnosis and Therapy of Hepatocellular Carcinoma.
    Hou XY; Jiang G; Yang CS; Tang JQ; Wei ZP; Liu YQ
    Recent Pat Anticancer Drug Discov; 2016; 11(3):322-31. PubMed ID: 26955964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in nanomedicine for hepatocellular carcinoma therapy].
    Xiong Q; Wang J; Bai Y; Song T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Apr; 35(2):314-319. PubMed ID: 29745540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment.
    Du Y; Liu D; Du Y
    J Drug Target; 2022 Mar; 30(3):287-301. PubMed ID: 34727794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma.
    Samie HAA; Saeed M; Faisal SM; Kausar MA; Kamal MA
    Curr Drug Metab; 2019; 20(4):283-291. PubMed ID: 30854953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial prospects of nano-targeted chemoimmunotherapy.
    Da Silva CG; Rueda F; Löwik CW; Ossendorp F; Cruz LJ
    Biomaterials; 2016 Mar; 83():308-20. PubMed ID: 26796043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
    Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
    Oncotarget; 2018 Jan; 9(2):2951-2961. PubMed ID: 29416827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities.
    Mohamed NK; Hamad MA; Hafez MZ; Wooley KL; Elsabahy M
    Int J Cancer; 2017 Apr; 140(7):1475-1484. PubMed ID: 27861850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives.
    Lyu Q; Peng L; Hong X; Fan T; Li J; Cui Y; Zhang H; Zhao J
    Biomaterials; 2021 Mar; 270():120682. PubMed ID: 33529961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotheranostics: Their role in hepatocellular carcinoma.
    Malla RR; Kumari S; Kgk D; Momin S; Nagaraju GP
    Crit Rev Oncol Hematol; 2020 Jul; 151():102968. PubMed ID: 32416345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosurgery in the realm of 10(-9), Part 2: applications of nanotechnology to neurosurgery--present and future.
    Elder JB; Liu CY; Apuzzo ML
    Neurosurgery; 2008 Feb; 62(2):269-84; discussion 284-5. PubMed ID: 18382306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: an update.
    Blum HE; Spangenberg HC
    Arch Iran Med; 2007 Jul; 10(3):361-71. PubMed ID: 17604475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment.
    Singh A; Shafi S; Upadhyay T; Najmi AK; Kohli K; Pottoo FH
    Curr Top Med Chem; 2020; 20(20):1839-1854. PubMed ID: 32579503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horizons of nanotechnology applications in female specific cancers.
    Rajitha B; Malla RR; Vadde R; Kasa P; Prasad GLV; Farran B; Kumari S; Pavitra E; Kamal MA; Raju GSR; Peela S; Nagaraju GP
    Semin Cancer Biol; 2021 Feb; 69():376-390. PubMed ID: 31301361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint.
    Karadag Soylu N
    J Gastrointest Cancer; 2020 Dec; 51(4):1176-1186. PubMed ID: 32844348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Ablation for Hepatocellular Carcinoma.
    Weinstein JL; Ahmed M
    AJR Am J Roentgenol; 2018 Jun; 210(6):1368-1375. PubMed ID: 29702018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.